NERV

Minerva Neurosciences, Inc.

NasdaqCMUSDEQUITY DELAYED

4.99

▲ 0.20 (4.18%)

MARKET · —

Price

Open

4.79

Prev close

4.79

Day high

5.07

Day low

4.79

Volume

105.06K

Market cap

—

P/E (TTM)

—

52W range

1.93 – 12.46

Trailing performance

Price return · vs SPY

Returnvs SPY

+5.68% +7.0%

+8.76% +5.0%

-8.68% -11.8%

-23.30% -34.4%

YTD

+20.40% +8.1%

+110.62% +90.6%

-44.94% -119.1%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

4.47

+11.53% from price

SMA 20

4.32

+12.06% from price

SMA 50

4.45

+8.72% from price

SMA 100

5.05

-1.28% from price

SMA 200

5.03

-3.83% from price

EMA 12

4.51

+10.61% from price

EMA 26

4.44

+12.39% from price

EMA 50

4.56

+9.38% from price

RSI (14)

58.5

Neutral

MACD (12,26,9)

0.07

Hist 0.09

ATR (14)

0.38

7.82% of price

Realised vol 30D

87.8%

Annualised

Bollinger upper

4.91

20, 2σ

Bollinger lower

3.73

20, 2σ

50 / 200 cross

Death

4.45 vs 5.03

Trend bias

Below 200

-3.83%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.56

More volatile than market

Correlation to SPY

0.12

Largely independent

Realised vol 30D

87.8%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-51.4%

Peak to trough

Max drawdown 5Y

-91.9%

Peak to trough

ATR 14

0.38

7.82% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 4.99

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

NERV · links out to the publisher

Minerva Neurosciences: Q2 Earnings Snapshot Associated Press · 15d ago Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates GlobeNewswire · 15d ago Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs GlobeNewswire · 82d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.